CD33 FPBMC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CD33 FPBMC, covering 2026-03-13 to 2026-03-13. Get the full timeline:
Most recent: Clinical Trial Update: Phase Ib Study of CD33 FPBMC in Patients With MRD+ AML or MDS [Phase 1]